+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Enanta Pharmaceuticals Inc - logo

Enanta Pharmaceuticals is a biotechnology company that focuses on small molecule drugs for viral infections and liver diseases. Enanta’s research is currently focused on the following disease targets: Hepatitis B Virus (HBV), Non-alcoholic Steatohepatitis (NASH)/PBC and Respiratory Syncytial Virus (RSV). The company has a collaborative development and license agreement with AbbVie to develop and commercialize HCV NS3 and NS3/4A protease inhibitors. Enanta was founded in 1995 and is headquartered in Watertown, Massachusetts.

Global Respiratory Syncytial Virus Market Size and Epidemiology (8MM), By Drug Type (Synagis, Other), By Dosage Form (Oral, Other), By Treatment Type (Immune prophylaxis, Other), By Distribution Channel (Clinics, Other) -Estimation & Forecast - Product Thumbnail Image

Global Respiratory Syncytial Virus Market Size and Epidemiology (8MM), By Drug Type (Synagis, Other), By Dosage Form (Oral, Other), By Treatment Type (Immune prophylaxis, Other), By Distribution Channel (Clinics, Other) -Estimation & Forecast

  • Report
  • June 2021
  • 675 Pages
  • Global
From
Hepatitis B Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hepatitis B Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 490 Pages
  • Global
From
Hepatitis Drugs Global Market Report 2024 - Product Thumbnail Image

Hepatitis Drugs Global Market Report 2024

  • Report
  • December 2023
  • 200 Pages
  • Global
From
Chronic Hepatitis B Virus Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Hepatitis B Virus Infection - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 200 Pages
  • Global
From
Hepatitis B Virus Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Hepatitis B Virus Infection - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 180 Pages
  • Global
From
Vancomycin - Global Strategic Business Report - Product Thumbnail Image

Vancomycin - Global Strategic Business Report

  • Report
  • April 2024
  • 78 Pages
  • Global
From
Hepatitis B Virus Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Hepatitis B Virus Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • February 2024
  • 101 Pages
  • Global
From
Global Vancomycin Market by Type (Ampicillin, Chloramphenicol, Daptomycin), Form (Capsule, Oral Solution (Liquid), Powder), Route of Administration, Application, Distribution Channel - Forecast 2024-2030 - Product Thumbnail Image

Global Vancomycin Market by Type (Ampicillin, Chloramphenicol, Daptomycin), Form (Capsule, Oral Solution (Liquid), Powder), Route of Administration, Application, Distribution Channel - Forecast 2024-2030

  • Report
  • March 2024
  • 197 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 307 Pages
  • Global
From
Non-Structural Protein 5 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Non-Structural Protein 5 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Therapeutics Global Market Report 2024 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
NASH Treatment & Therapeutics Market Report 2023-2033 - Product Thumbnail Image

NASH Treatment & Therapeutics Market Report 2023-2033

  • Report
  • July 2023
  • 224 Pages
  • Global
From
Respiratory syncytial virus (RSV) - Pipeline Insight, 2024 - Product Thumbnail Image

Respiratory syncytial virus (RSV) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Hepatitis B - Pipeline Review, H2 2020 - Product Thumbnail Image

Hepatitis B - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 575 Pages
  • Global
From
Vancomycin-Resistant Enterococcus Faecium Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Vancomycin-Resistant Enterococcus Faecium Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 96 Pages
  • Global
From
Antiviral Drugs Market by Mechanism of Action, Target Indication, Type of Drug Target, Type of Therapy and Key Geographies: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Antiviral Drugs Market by Mechanism of Action, Target Indication, Type of Drug Target, Type of Therapy and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • September 2022
  • 194 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Infections Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Infections Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • November 2023
  • 270 Pages
  • Global
From
Nonalcoholicsteatohepatitis (NASH) Pipeline Analysis - Forecast to 2026 - Product Thumbnail Image

Nonalcoholicsteatohepatitis (NASH) Pipeline Analysis - Forecast to 2026

  • Report
  • August 2018
  • 197 Pages
  • Global
From
Liver Diseases Therapeutics Global Market Report 2024 - Product Thumbnail Image

Liver Diseases Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Loading Indicator